The alpha-fetoprotein (AFP) is one of the most widely used HCC biomarkers in the world (Zhu et al. 2018a), but it is still controversial as a HCC biomarker (Yuan et al. 2019; Ding et al. 2020). This evidence concerns the gene AFP and hepatocellular carcinoma.